PURPOSE: To determine whether perfusion-cultured bovine anterior segments would be a suitable model for glaucoma research. METHODS: Fresh bovine eyes were dissected and sealed on a custom-made acrylic dish with an O-ring. Perfusion medium was infused by a syringe pump at a constant infusion rate of 5 μL/min. After intraocular pressure (IOP) was stable, bovine eyes were perfused with medium containing either a vehicle control (0.1% ethanol [ETH]) or dexamethasone (DEX) for up to 7 days. IOP was recorded by a pressure transducer and a computerized system. Perfusion medium was collected for Western immunoblot analysis of myocilin (MYOC). RESULTS: The morphology of the bovine trabecular meshwork after perfusion culture was similar to that of freshly dissected, nonperfused bovine eyes. Treatment with DEX elevated IOP in some bovine eyes, whereas others showed little change. The authors analyzed the data from 18 ETH-treated control eyes and defined 2.82 mm Hg as the threshold of ocular hypertension (OHT), which equals mean pressure change + 2× SD. Approximately 40% (12/29) of the bovine eyes were DEX responders, which is very close to the DEX-responsive rates observed in human and monkey eyes. Western blot data showed that DEX treatment induced the expression of the DEX-inducible gene MYOC only in the perfusion-cultured anterior segments with DEX-induced OHT. CONCLUSIONS: OHT can be induced by DEX in perfusion-cultured bovine anterior segments. This is a fast, convenient, affordable, and reliable model for studying DEX-induced OHT and the mechanisms of trabecular outflow.
PURPOSE: To determine whether perfusion-cultured bovine anterior segments would be a suitable model for glaucoma research. METHODS: Fresh bovine eyes were dissected and sealed on a custom-made acrylic dish with an O-ring. Perfusion medium was infused by a syringe pump at a constant infusion rate of 5 μL/min. After intraocular pressure (IOP) was stable, bovine eyes were perfused with medium containing either a vehicle control (0.1% ethanol [ETH]) or dexamethasone (DEX) for up to 7 days. IOP was recorded by a pressure transducer and a computerized system. Perfusion medium was collected for Western immunoblot analysis of myocilin (MYOC). RESULTS: The morphology of the bovine trabecular meshwork after perfusion culture was similar to that of freshly dissected, nonperfused bovine eyes. Treatment with DEX elevated IOP in some bovine eyes, whereas others showed little change. The authors analyzed the data from 18 ETH-treated control eyes and defined 2.82 mm Hg as the threshold of ocular hypertension (OHT), which equals mean pressure change + 2× SD. Approximately 40% (12/29) of the bovine eyes were DEX responders, which is very close to the DEX-responsive rates observed in human and monkey eyes. Western blot data showed that DEX treatment induced the expression of the DEX-inducible gene MYOC only in the perfusion-cultured anterior segments with DEX-induced OHT. CONCLUSIONS: OHT can be induced by DEX in perfusion-cultured bovine anterior segments. This is a fast, convenient, affordable, and reliable model for studying DEX-induced OHT and the mechanisms of trabecular outflow.
Authors: Yuan Lei; Darryl R Overby; Alexandra Boussommier-Calleja; W Daniel Stamer; C Ross Ethier Journal: Invest Ophthalmol Vis Sci Date: 2011-03-29 Impact factor: 4.799
Authors: Marcel J M Schaaf; Danielle Champagne; Ivo H C van Laanen; Diane C W A van Wijk; Annemarie H Meijer; Onno C Meijer; Herman P Spaink; Michael K Richardson Journal: Endocrinology Date: 2007-12-20 Impact factor: 4.736
Authors: N C Wade; I Grierson; S O'Reilly; M J Hoare; K P B Cracknell; L I Paraoan; D Brotchie; A F Clark Journal: Exp Eye Res Date: 2009-06-21 Impact factor: 3.467
Authors: Darryl R Overby; Jacques Bertrand; Ozan-Yüksel Tektas; Alexandra Boussommier-Calleja; Martin Schicht; C Ross Ethier; David F Woodward; W Daniel Stamer; Elke Lütjen-Drecoll Journal: Invest Ophthalmol Vis Sci Date: 2014-07-15 Impact factor: 4.799
Authors: Amir Vahabikashi; Chan Young Park; Kristin Perkumas; Zhiguo Zhang; Emily K Deurloo; Huayin Wu; David A Weitz; W Daniel Stamer; Robert D Goldman; Jeffrey J Fredberg; Mark Johnson Journal: Biophys J Date: 2019-01-07 Impact factor: 4.033
Authors: Thania Bogarin; Sindhu Saraswathy; Goichi Akiyama; Xiaobin Xie; Robert N Weinreb; Jie Zheng; Alex S Huang Journal: Exp Eye Res Date: 2019-08-23 Impact factor: 3.467
Authors: M Elizabeth Fini; Stephen G Schwartz; Xiaoyi Gao; Shinwu Jeong; Nitin Patel; Tatsuo Itakura; Marianne O Price; Francis W Price; Rohit Varma; W Daniel Stamer Journal: Prog Retin Eye Res Date: 2016-09-22 Impact factor: 21.198